Journal pulls scientific paper that popularized hydroxychloroquine as COVID-19 treatment
- A COVID study that promoted an unproven treatment has been retracted after a four-year saga.
- The study faced significant scrutiny and criticism from the scientific community throughout its publication.
- Many experts expressed concerns about the implications of promoting unproven treatments during the pandemic.
- The retraction marks the end of an ongoing discussion about the study's impact on COVID treatment.
38 Articles
38 Articles
The widely contested study that popularized the idea of using hydroxychloroquine against Covid was “unpublished” last Tuesday (17). The publisher Elsevier, responsible for the journal in which the research was published, conducted an investigation and pointed out that the portrayal is related to ethical issues and to possible flaws in the scientific method. Read more (12/20/2024)
A controversial study on the effectiveness of the malaria drug hydroxychloroquine against corona has been withdrawn after more than four years.
Scandalous study on the use of hydroxychloroquine against COVID-19 is officially retractedDidier Raoul's scientific study on the treatment of COVID-19 with hydroxychloroquine has been withdrawn due to violations of ethical norms and methodology. The commission found that not all patients consented to participate in the study.
Coverage Details
Bias Distribution
- 75% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
